Young children in digital society: An Online Tool for service provision . This project aims to identify the practices enacted and shared amongst young children, their families and educators in digital society.The project is significant because in digital society families and educators face new demands ensuring technologies are used in the best interests of young children. Knowledge about practices in digital society informs adult decision-making using technologies with, by and for young children ....Young children in digital society: An Online Tool for service provision . This project aims to identify the practices enacted and shared amongst young children, their families and educators in digital society.The project is significant because in digital society families and educators face new demands ensuring technologies are used in the best interests of young children. Knowledge about practices in digital society informs adult decision-making using technologies with, by and for young children in the early years. The outcome is a new Online Tool for the Partner Organisations to share exemplar practices benefiting Australian children, their families and educators with new resources, materials and programs in areas including: digital media production, cyber-safety education, digital play and digital parenting.
Read moreRead less
The Kids in Communities Study: national investigation of community level effects on children's developmental outcomes. This project (a cross-disciplinary collaboration) will investigate community level factors influencing early childhood developmental outcomes using a mixed methods approach in up to 10 communities across Australia. This will result in a potential set of measures or indicators that reflect communities that are good for children.
Pharmacology Of Potential Anti-Tumour Agents: Iron Chelators Of The BpT Class
Funder
National Health and Medical Research Council
Funding Amount
$585,455.00
Summary
Pharmacology of Potential Anti-Tumour Agents: Iron Chelators of the BpT Class Cancer cells have a high iron requirement for DNA synthesis and many clinical trials showed Fe chelators are effective anti-cancer drugs. Their potential to act as anti-tumour agents has been confirmed by the entrance of Triapine into widespread NCI clinical trials. In this NHMRC Renewal, we will perform pharmacological and preclinical studies to promote the development of BpT chelators as novel anti-tumour agents.